Dina Goytia-Leos
Internal Medicine · San Antonio, TXNPI 1275503526
Payments from drug & device makers
Across 122 payments — averaging $32.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$1K
- Novo Nordisk$604
- Abbott$435
- Merck$173
- Amgen$153
- Medtronic$139
- plus $1K from 21 others
What the payments were for
- Travel & lodging$97825%
- Food & beverage$2,96075%
- Education$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 8 | $1,285 |
| Novo Nordisk | 31 | $604 |
| Abbott | 9 | $435 |
| Merck | 10 | $173 |
| Amgen | 8 | $153 |
| Medtronic | 1 | $139 |
| Corcept Therapeutics | 2 | $137 |
| Gilead | 2 | $127 |
| Daiichi Sankyo Inc. | 5 | $98 |
| Novartis | 6 | $97 |
| Lilly USA, LLC | 6 | $95 |
| Pfizer | 5 | $82 |
| Astellas Pharma US Inc | 5 | $74 |
| Bayer | 2 | $56 |
| AbbVie | 3 | $50 |
| AstraZeneca | 3 | $48 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $47 |
| Kowa Pharmaceuticals America, Inc. | 3 | $39 |
| Amarin Pharma, Inc. | 2 | $39 |
| Idorsia Pharmaceuticals US Inc | 2 | $28 |
| Boehringer Ingelheim | 1 | $28 |
| GSK | 1 | $25 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $17 |
| Intuity Medical Inc | 1 | $13 |
| IBSA Pharma Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,110
- FreeStyle Libre$191
- KYPHON Balloon Kyphoplasty$139
- Korlym$133
- FREESTYLE LIBRE 3$130
- Saxenda$119
- Descovy$116
How this compares
$3,942 in reported general payments places this provider in the 85th percentile of 7,675 internal medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 61 | $69,946 |
| OzempicSemaglutide | 24 | $29,996 |
| MounjaroTirzepatide | 18 | $21,189 |
| JanuviaSitagliptin Phosphate | 17 | $17,203 |
| TrulicityDulaglutide | 17 | $14,973 |
| EliquisApixaban | 11 | $10,665 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $4,582 |
| SynthroidLevothyroxine Sodium | 22 | $2,019 |
| Levothyroxine Sodium | 108 | $1,639 |
| PaxlovidNirmatrelvir/Ritonavir | 14 | $1,429 |
| Celecoxib | 27 | $984 |
| Losartan Potassium | 96 | $933 |
| Ezetimibe | 20 | $843 |
| Atorvastatin Calcium | 98 | $732 |
| Famotidine | 28 | $664 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $28 | $69,94661 claims |
| Lilly USA, LLCMounjaro, Trulicity | $95 | $36,16235 claims |
| Novo NordiskOzempic | $604 | $29,99624 claims |
| MerckJanuvia | $173 | $17,20317 claims |
| PfizerEliquis, Paxlovid | $82 | $12,09525 claims |
| GSKBreo Ellipta | $25 | $4,58213 claims |
| AbbVieSynthroid | $50 | $2,01922 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,675 internal medicine providers in Texas.
Other internal medicine in San Antonio
- Robert BassSan Antonio$25.6M
- Hernan SalazarSan Antonio$18.5M
- Dennis RuffSan Antonio$7.5M
- Cassandra KeySan Antonio$5.6M
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.